新华制药子公司获熊去氧胆酸胶囊药品注册证书

Core Viewpoint - Xinhua Pharmaceutical (000756.SZ) announced that its wholly-owned subsidiary, Shandong Zibo Xinda Pharmaceutical Co., Ltd., has received the drug registration certificate for Ursodeoxycholic Acid Capsules from the National Medical Products Administration, indicating a significant regulatory approval for a new treatment option [1] Group 1 - The approved drug is indicated for the treatment of cholesterol gallstones, specifically those that are X-ray penetrable and require normal gallbladder contraction function [1] - The drug is also used for cholestatic liver diseases, such as primary biliary cirrhosis [1] - Additionally, it is indicated for the treatment of bile reflux gastritis [1]